Amtagvi Approved by the FDA for Treatment of Advanced Melanoma
TUESDAY, Feb. 20, 2024 -- Amtagvi (lifileucel) has been approved by the U.S. Food and Drug Administration for the treatment of advanced melanoma. Amtagvi becomes the first cellular therapy approved to treat this form of solid tumor cancer. " The... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 20, 2024 Category: Pharmaceuticals Source Type: news

Life Plasma Receives FDA Approval for its Reading, PA Plasma Collection Center
Life Plasma, a leading plasma company specializing in the collection of human plasma, used to make plasma-derived medicines, has announced today that it has received approval from the U.S. Food and Drug Administration ("FDA") for its plasma collection facility located in Reading, PA.... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 19, 2024 Category: Pharmaceuticals Tags: FDA Source Type: news

FDA Approves New Treatment for Advanced Melanoma, Amtagvi
MONDAY, Feb. 19, 2024 -- The U.S. Food and Drug Administration has approved a novel treatment for advanced melanoma, the most deadly form of skin cancer. Amtagvi, made by Iovance Biotherapeutics Inc., becomes the first cellular therapy approved to... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 19, 2024 Category: General Medicine Source Type: news

Seniors, FDA Has 5 Medication Tips to Keep You Safe
MONDAY, Feb. 19, 2024 -- When settling into your senior years, you need to be especially careful when taking medicines, herbal remedies and supplements, the U.S. Food and Drug Administration says. That’s because older adults are likely to use... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 19, 2024 Category: General Medicine Source Type: news

FDA Approves First Medication To Treat Severe Frostbite
The US Food and Drug Administration has approved the first injectable medication to treat frostbite. Actelion Pharmaceutical’s Aurlumyn uses main ingredient iloprost to dilate blood vessels and prevent blood from clotting, reducing the risk…#fda #normanstockbridge #epochtimes #aurlumyn #bringingnewhope #newsmax (Source: Reuters: Health)
Source: Reuters: Health - February 19, 2024 Category: Consumer Health News Source Type: news

Cheddar cheese recall as warning issued over potential illness
The U.S. Food and Drug Administration (FDA) has announced the recall of Raw Farm cheddar cheese products after several people fell ill. Two cheddar cheese blocks and one shredded cheese product have been voluntarily recalled by Raw Farm after illnesses were reported between October 18, 2023, and…#fda #rawfarm #sproutsfarmersmarket #bristolfarms #colorado #utah (Source: Reuters: Health)
Source: Reuters: Health - February 18, 2024 Category: Consumer Health News Source Type: news

In'major milestone,' FDA approves first cell therapy for solid tumors
Nearly four decades after its first conception, the first TIL therapy, an immunotherapy that harvests cancer-fighting immune cells from the patient’s own body, received accelerated approval from the Food and Drug Administration for advanced melanoma. The therapy, called Amtagvi or lifileucel from…#iovance #allisonbetofwarner #stanforduniversity #betofwarner (Source: Reuters: Health)
Source: Reuters: Health - February 17, 2024 Category: Consumer Health News Source Type: news

FDA Approves First Cellular Therapy to Treat Patients with Unresectable or Metastatic Melanoma
Today, the U.S. Food and Drug Administration approved Amtagvi, the first cellular therapy indicated for the treatment of adult patients with a type of skin cancer (melanoma) that is unable to be removed with surgery (unresectable) or has spread to other parts of the body (metastatic) that…#pd1 #braf #mek #petermarks #phd #fda #melanoma #nicoleverdun #acceleratedapproval #effectiveness (Source: Reuters: Health)
Source: Reuters: Health - February 17, 2024 Category: Consumer Health News Source Type: news

Expanded Use of Xolair to Treat Food Allergies Approved by the FDA
FRIDAY, Feb. 16, 2024 -- The U.S. Food and Drug Administration has expanded the use of the asthma drug Xolair (omalizumab) to help prevent anaphylactic reactions.Xolair is an injected drug and is not meant as a substitute for EpiPens or other... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 17, 2024 Category: Pharmaceuticals Source Type: news

FDA Roundup: February 16, 2024
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 16, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA Expands Use of Asthma Med Xolair to Treat Food Allergies
FRIDAY, Feb. 16, 2024 -- People threatened by accidental exposure to foods they ' re allergic to may have a new weapon of defense: On Friday, the U.S. Food and Drug Administration expanded the use of the asthma drug Xolair to help prevent... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 16, 2024 Category: General Medicine Source Type: news

FDA Approves Xolair as First and Only Medicine for Children and Adults With One or More Food Allergies
South San Francisco, CA -- February 16, 2024 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Xolair® (omalizumab) for the reduction of allergic... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - February 16, 2024 Category: Drugs & Pharmacology Source Type: news

FDA approves Xolair as first and only medicine for children and adults with one or more food allergies
Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate small amounts of peanut, milk, egg and cashew without an allergic reaction, compared to placeboMore than 40% of children and more than half of adults with food allergies have experienced a severe reaction at least once1,2   Detailed OUtMATCH results will be featured in a late-breaking symposiumat the 2024 AAAAI Annual MeetingBasel, 16  February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food ...
Source: Roche Investor Update - February 16, 2024 Category: Pharmaceuticals Source Type: news

FDA approves Xolair as first and only medicine for children and adults with one or more food allergies
Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate small amounts of peanut, milk, egg and cashew without an allergic reaction, compared to placeboMore than 40% of children and more than half of adults with food allergies have experienced a severe reaction at least once1,2   Detailed OUtMATCH results will be featured in a late-breaking symposiumat the 2024 AAAAI Annual MeetingBasel, 16  February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food ...
Source: Roche Media News - February 16, 2024 Category: Pharmaceuticals Source Type: news

FDA Approves Eohilia for Eosinophilic Esophagitis
FRIDAY, Feb. 16, 2024 -- The U.S. Food and Drug Administration has approved Eohilia (budesonide oral suspension) as the first and only oral treatment for eosinophilic esophagitis (EoE). The oral corticosteroid therapy is approved for individuals... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 16, 2024 Category: Pharmaceuticals Source Type: news